Peptide-Based Therapeutics: Developing And Scaling Through Innovative Technologies

Peptide-based therapeutics are experiencing rapid growth in both clinical and commercial sectors, increasing the demand for technologies that can effectively develop and scale these candidates. While manufacturing peptides can be complex, emerging techniques such as liquid-phase peptide synthesis (LPPS) and peptide crystallization offer promising solutions for more cost-efficient and environmentally sustainable production.

In this webinar, Cambrex experts will explore various technologies and case studies, focusing on LPPS, peptide crystallization, method development for peptide impurity analysis, and more.

Key topics will include a comparison of liquid-phase and solid-phase peptide synthesis, process development workflows for scalable production of peptide fragment building blocks, the advantages of peptide crystallization, and the use of HPLC techniques for analyzing peptide purity and impurities. Additionally, the webinar will cover the determination of intact mass and peptide sequencing for identification using LC-MS.